Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06414473
PHASE1/PHASE2

CBD for Knee Osteoarthritis

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

Osteoarthritis is a disease that affects millions of Americans and is the leading cause of persistent pain and physical disability in the older adult population. Many physically active Americans have reported pain-relieving effects of cannabidiol (CBD) that can reduce or eliminate use of nonsteroidal anti-inflammatory drugs (NSAIDs) for activity-related pain with minimal to no side effects. Long-term use of over-the-counter medications, including NSAIDs, can pose a significant health risk, and therefore clinical research on the safety and efficacy of CBD is needed.

Official title: Sub-Lingual Administration of Cannabidiol for Knee Osteoarthritis

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-06-14

Completion Date

2026-12-31

Last Updated

2025-09-17

Healthy Volunteers

No

Interventions

DRUG

Cannabidiol (CBD) Extract

Administered thrice daily (with food) using a sublingual route of administration

DRUG

Placebo

Administered thrice daily (with food) using a sublingual route of administration

Locations (1)

Sports Medicine Research Laboratory

Gainesville, Florida, United States